Sign Up to like & get
recommendations!
1
Published in 2022 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2022.2037552
Abstract: ABSTRACT Introduction Pancreatic ductal adenocarcinoma (PDAC) has a 5-year overall survival rate of 10%, emphasizing the need for more effective therapies, especially in metastatic disease. The immunosuppressive tumor microenvironment, poor vascularization, and dense tumor stroma…
read more here.
Keywords:
treatment approaches;
metastatic pancreatic;
approaches metastatic;
systemic treatment ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Cell and Developmental Biology"
DOI: 10.3389/fcell.2022.1048630
Abstract: Genetic heterogeneity of metastatic dissemination has proven challenging to identify exploitable markers of metastasis; this bottom-up approach has caused a stalemate between advances in metastasis and the late stage of the disease. Advancements in quantitative…
read more here.
Keywords:
imaging approaches;
cell;
state;
approaches metastatic ... See more keywords